Cerebrospinal fluid concentration of metoprolol in a hypertensive patient.
作者信息
WOOD A J
出版信息
Br J Clin Pharmacol. 1977 Apr;4(2):240-1. doi: 10.1111/j.1365-2125.1977.tb00702.x.
Abstract
摘要
相似文献
1
Cerebrospinal fluid concentration of metoprolol in a hypertensive patient.一名高血压患者脑脊液中美托洛尔的浓度
Br J Clin Pharmacol. 1977 Apr;4(2):240-1. doi: 10.1111/j.1365-2125.1977.tb00702.x.
2
beta-Adrenoreceptor-blocking agents and the blood-brain barrier.β-肾上腺素能受体阻滞剂与血脑屏障
Clin Sci (Lond). 1980 Dec;59 Suppl 6:453s-455s. doi: 10.1042/cs059453s.
3
[Effect and concentration in plasma of metoprolol after administration in the morning and in the evening in essential hypertension].[原发性高血压患者早晨和晚上服用美托洛尔后的效果及血浆浓度]
Lakartidningen. 1978 Mar 15;75(11):1069-72.
4
Disposition of metoprolol in the newborn.美托洛尔在新生儿体内的处置情况。
Br J Clin Pharmacol. 1981 Oct;12(4):598-600. doi: 10.1111/j.1365-2125.1981.tb01276.x.
5
A pharmacokinetic comparison between different slow-release formulations of metoprolol (Lopresor SR and Betaloc SA).美托洛尔不同缓释制剂（倍他乐克缓释片和琥珀酸美托洛尔缓释片）之间的药代动力学比较。
Br J Clin Pharmacol. 1981 Oct;12(4):600-2. doi: 10.1111/j.1365-2125.1981.tb01277.x.
6
7
Experiences with metoprolol Durules, a slow-release formulation in hypertension.
J Int Med Res. 1980;8(1):44-9. doi: 10.1177/030006058000800108.
8
[Verapamil-hydrochlorothiazide vs. metoprolol-hydrochlorothiazide. Trial in hypertensive patients].[维拉帕米-氢氯噻嗪与美托洛尔-氢氯噻嗪对比。高血压患者试验]
Arq Bras Cardiol. 1981 Mar;36 Suppl 1:33-5.
9
Sustained release metoprolol: a comparison with conventional formulation in the treatment of hypertension.
N Z Med J. 1981 Jul 8;93(687):1-2.
10
[Effects of metoprolol and of the combination of metoprolol and hydrochlorothiazide arterial hypertension patients].[美托洛尔及美托洛尔与氢氯噻嗪联合用药对高血压患者的影响]
Boll Soc Ital Cardiol. 1980;25(4):333-45.
引用本文的文献
1
The penetration of acebutolol and its major metabolite, diacetolol, into human cerebrospinal fluid and saliva.醋丁洛尔及其主要代谢物双醋洛尔在人脑脊液和唾液中的渗透情况。
Br J Clin Pharmacol. 1981 Sep;12(3):427-9. doi: 10.1111/j.1365-2125.1981.tb01239.x.
2
Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.醋丁洛尔。其药理学特性及在高血压、心绞痛和心律失常治疗中的疗效综述。
Drugs. 1985 Jun;29(6):531-69. doi: 10.2165/00003495-198529060-00003.
3
Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.美托洛尔：其药理学特性及在高血压和心绞痛治疗中的疗效综述。
Drugs. 1977 Nov;14(5):321-48. doi: 10.2165/00003495-197714050-00001.
本文引用的文献
1
Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey.大鼠、犬和猴体内普萘洛尔的吸收、分布及排泄研究。
J Pharmacol Exp Ther. 1971 Feb;176(2):302-11.
2
Cardiovascular effects of intracerebroventricular d-, l- and dl-propranolol in the conscious rabbit.脑室内注射d-、l-和dl-普萘洛尔对清醒家兔心血管系统的影响。
J Pharmacol Exp Ther. 1974 Feb;188(2):394-9.
3
The metabolism and distribution of the selective adrenergic beta blocking agent, practolol.选择性肾上腺素β受体阻滞剂心得宁的代谢与分布
J Pharmacol Exp Ther. 1970 Nov;175(2):338-47.
4
Central adrenoreceptors and the control of arterial blood pressure.中枢肾上腺素能受体与动脉血压的调控
Clin Exp Pharmacol Physiol. 1974 Jul-Aug;1(4):347-60. doi: 10.1111/j.1440-1681.1974.tb00557.x.
5
Binding of two adrenergic beta-receptor antagonists, alprenolol and H 93-26, to human serum proteins.两种肾上腺素能β受体拮抗剂阿普洛尔和H 93 - 26与人血清蛋白的结合。
Acta Pharm Suec. 1974 Sep;11(4):333-46.
6
Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man.心得安在兔体内的脑内浓度与降压作用的关系及对人体脑内心得安水平的观察
J Pharmacol Exp Ther. 1975 Feb;192(2):327-35.
7
Tissue distribution of metoprolol-(3-h) in the mouse and the rat.美托洛尔 -（3 - H）在小鼠和大鼠体内的组织分布
Acta Pharmacol Toxicol (Copenh). 1975;36(Suppl 5):116-24. doi: 10.1111/j.1600-0773.1975.tb03328.x.
8
Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.β-肾上腺素受体阻断药的临床药代动力学
Clin Pharmacokinet. 1976;1(4):233-63. doi: 10.2165/00003088-197601040-00001.
Zotero 插件